Spain, Dec. 26 -- Spain based UCB PHARMA, S.A. has secured contract from Organo Administrativo de Recursos Contractuales de la Comunidad Autonoma de Euskadi for Pharmaceutical products - Suministro de Rozanolixizumab (DOE). The value of the contract is worth 56233870 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....